Senior insider sale
Chief Business Officer at CORCEPT THERAPEUTICS INC — senior position signals high conviction
$1.16M
10K shares
What this filing means
ROBB GARY CHARLES plans to sell 10K shares of CORCEPT THERAPEUTICS INC valued at approximately $1.16M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/17/2026ACC: 0001972481-26-000262
Officer· Chief Business Officer
Since Mar 2026
10K
Shares to sell
$1.16M
Approx. market value
64.72K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Owned Shares
Equity Compensation
12/31/2025
64.72KTotal acquired64.72K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/31/2025 | Owned Shares Equity Compensation | 64.72K | — |
| Total | 64.72K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
10K
Market value
$1.16M
8/17/2026
Total
Units
10K
Value
$1.16M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/17/2026 | 10K | $1.16M | Nasdaq | Planned |
| Total | 10K | $1.16M | ||